This distribution of TGFβ-1 was different from what was observed in a previous study by Webber et al. (2010), where they suggested that only ~2% of the TGFβ-1 from mesothelioma or prostate cancer cell line-derived exosomes was in the active form [13]. The gene discussed is TGFB1; the disease is prostate carcinoma.